跳至主要内容
临床试验/NCT01524276
NCT01524276招募中不适用

Medtronic Product Surveillance Registry

Medtronic395 个研究点 分布在 1 个国家目标入组 100,000 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Medtronic
入组人数
100,000
试验地点
395
主要终点
Safety and Effectiveness of Market Released products

研究概览

简要总结

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • Patient has or is intended to receive or be treated with an eligible Medtronic product
  • Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

排除标准

  • Patient who is, or will be, inaccessible for follow-up
  • Patient with exclusion criteria required by local law
  • Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

结局指标

主要结局

Safety and Effectiveness of Market Released products

时间窗: Every 6-12 months (Therapy-dependent)

次要结局

未报告次要终点

研究者

发起方
Medtronic
申办方类型
Industry
责任方
Sponsor

研究点 (395)

Loading locations...

相似试验